title: Cytotoxicity evaluation of sodium alendronate on cultured human periodontal ligament fibroblasts.
abstract: External root resorption processes are usually associated with dental trauma, mainly avulsion and intrusion. In such cases endodontic therapy aims to prevent this process by using medications that can inhibit osteoclastic activity, such as bisphosphonates. However, these drugs must be biocompatible to the periapical tissues. The aim of this study was to analyze the cytotoxicity of a bisphosphonate (sodium alendronate) on human periodontal ligament fibroblasts (PDL cells). Cells were plated in a density of 1 x 10(3) cells per dish. The experimental groups were GI (control) no sodium alendronate, and GII, GIII, and GIV with sodium alendronate at the concentrations of 10(-5), 10(-6), and 10(-7) M, respectively. The experimental times were 1, 6, 12, and 24 h (short-term) for viability and 2, 4, 6, and 8 days (long-term) for cell survival. Data in triplicate were statistically analyzed. Cultures treated with the highest alendronate concentration (GII) showed cell viability percentages significantly lower (P < 0.01) than those of the other groups (GI, GIII, and GIV), at 12 and 24 h. Cell growth on GII and GIII groups was similar. GII presented smaller growth than the other groups (P < 0.05). We concluded that sodium alendronate, on direct contact with human periodontal ligament fibroblasts, is cytotoxic in concentrations higher than of 10(-6) M.
authors.affiliation: Department of Endodontics, School of Dentistry, University of São Paulo, São Paulo, Brazil.
authors.forename: Vera de Fátima Padrão
authors.initials: Vde F
authors.lastname: Correia
authors.forename: Celso L
authors.initials: CL
authors.lastname: Caldeira
authors.forename: Márcia Martins
authors.initials: MM
authors.lastname: Marques
mesh_terms: D019386:Alendronate / Q000009:adverse effects*; D000704:Analysis of Variance; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D002452:Cell Count; D002470:Cell Survival / Q000187:drug effects; D004353:Drug Evaluation, Preclinical; D005347:Fibroblasts / Q000187:drug effects*; D006801:Humans; D010513:Periodontal Ligament / Q000166:cytology*
chemical_list: D050071:Bone Density Conservation Agents; D019386:Alendronate